Clinical outcome and predictors of survival after TIPS insertion in patients with liver cirrhosis

Table 1 Baseline characteristics

Variables	Bleeding	Ascites	P value
Patients	54	27
Age (yr)			0.497
mean ± SD	61.7 ± 10.4	63.3 ± 10.8
Range	38-79	46-84
Sex (male/female)	33/21	15/12	0.634
CHILD score
A	24	6	0.052
B	28	18	NS
C	2	3	NS
MELD score	9.4 ± 4.9	13.7 ± 5.2	< 0.001
Underlying disease
Chronic viral hepatitis B/C	7/1	2/1	0.949
Alcohol abuse	38	21	NS
Autoimmune hepatitis	2	0	NC
PSC/PBC	3	0	NC
Cryptogen	3	3	NS
Re-bleeding after TIPS	13	0	NC
PPG before TIPS (mmHg)	23.4 ± 5.3	22.1 ± 5.5	0.765
PPG after TIPS (mmHg)	11.8 ± 4.0	11.7 ± 4.2	0.883
Stent diameter1 (mm)
< 12/≥ 12	6/44	4/23	0.728
Anticoagulation after TIPS	31	9	0.042
LTX after TIPS	7	1	0.131
Median survival time (mo)	> 60	29	0.009
Number of radiological controls until evaluation	6.3 ± 4.8	3.8 ± 3.1	0.029
Time interval until first radiological control	9.3 ± 10.6	4.5 ± 5.6	0.133

¹In four patients data acquisition of stent diameter not available. NS: Not significant; NC: Not calculated; LTX: Liver transplantation; TIPS: Transjugular intrahepatic portosystemic stent; PPG: Portal pressure gradient; MELD: Model for end-stage liver disease; PSC: Primary sclerosing cholangitis; PBC: Primary biliary cirrhosis.